290650.KQ
엘앤씨바이오
KOE · Healthcare · Medical - Specialties · KR
KRW 46,500.00
+1.75%Next report
Analyst consensus
- Next report date
- Nov 18, 2026
- EPS estimate
- KRW 252
- Revenue estimate
- KRW 42.1B
Latest reported
- Last report date
- Aug 11, 2026
- EPS actual
- KRW 128
- EPS estimate
- KRW 141
- Revenue actual
- KRW 38.3B
- Revenue estimate
- KRW 38.3B
Track record
Trailing twelve quarters
- EPS beats (12Q)
- 0
- EPS misses (12Q)
- 1
- EPS in line (12Q)
- 0
- Avg surprise (4Q)
- -9.1%
- Revenue beats (12Q)
- 0
No earnings call summaries available
Reported history
| Report date | EPS estimate | EPS actual | Surprise | Revenue actual |
|---|---|---|---|---|
| Aug 11, 2026 | KRW 141 | KRW 128 | Miss -9.07% | KRW 38.3B |
| May 11, 2026 | — | KRW 105 | — | KRW 27.0B |
Reported results against consensus at the time of each report · Surprise is computed from the estimate on record · Data as of Nov 18, 2026